Events

Global IVD Market Review

December 3, 2024
11:00 AM – 12:00 PM

Register now

Join IQVIA MedTech and Cepheid as we explore how the IVD market is evolving and where the opportunities for your business lie.

Global IVD Market Review

December 3, 2024
11:00 AM – 12:00 PM

Register now

  1. Overview
  2. Speakers

Global IVD Market Review

December 3, 2024
11:00 AM – 12:00 PM

Register now

Is your business ahead of the curve in a dynamic In vitro diagnostics (IVD) market that is rebounding post-Covid? Do you have the data and insights needed to beat the competition and uncover the untapped growth opportunities in the market? Join IQVIA MedTech and Cepheid as we explore how the IVD market is evolving and where the opportunities for your business lie.

During this webinar experts will explore:
• Key IVD market trends and where the expansion opportunities are appearing
• How regional market performance is shaping the IVD environment
• Who are the top performing IVD Manufacturers
• What are the future market drivers and barriers 

Meet The Speakers

Mark Girardi – Principal, Head of IVD Diagnostic Consulting, IQVIA

Mark Girardi has over 30 years of experience in life sciences, in vitro diagnostics, and medical devices commercialization and reimbursement. He has experience in product management, sales, marketing, and strategy consulting. Mark is currently Principal, Head of In Vitro/Medical Diagnostics at IQVIA MedTech.

Previously, Mark held roles as a Partner with Clarivate DRG, leading the firm’s MedTech practice area, and as Senior Vice President at Boston Healthcare Associates(BHA). While at BHA, his focus was on the Medical Technology space working with clients in the medical device, diagnostics, and digital health areas. His area of specialization was supporting the commercialization of innovative technologies with a focus on global reimbursement, market access and commercialization advisory services.

Prior to this, Mark was with GfK Health, a global consultancy and market research firm, where he was Senior Vice President responsible for the MedTech consulting practice. Before joining GfK, he spent five years at Predictive Biosciences as VP of Sales and Marketing. He also served as Senior Director of Marketing at Z-Tech Medical where he was responsible for commercialization of the company’s breast cancer screening devices. As Director of Marketing at Cytyc Corporation (now Hologic), he managed the worldwide launch of the Thin Prep Imaging System. He has also held senior marketing positions at Genzyme Genetics and Millipore.

Mark received his BS in Chemistry from Merrimack College and an MS in Analytical Chemistry from the University of New Hampshire.



Divyaa Ravishankar –  Senior Manager, Global Strategy, Cepheid

Divyaa Ravishankar is a Senior Manager, Corporate Strategy at Cepheid, where she guides growth initiatives and oversees market trends and commercial strategies. With 15 years in healthcare, Divyaa has extensive experience in in vitro diagnostics through roles at NAMSA, Frost & Sullivan, and Histogenetics. She has led strategic consulting and product marketing for both IVD startups and established firms. Recognized for her expertise, Divyaa has been cited in leading media outlets such as Forbes, WSJ, StarMedImmune,Bio IT World, Nova Medica,  for her thought leadership and strategic insights. She is also a sought-after speaker and workshop leader at major industry events across the U.S,Asia.

Beyond her professional achievements, she actively generates awareness through local radio channels, influencer programs by hosting panel discussions on topics related to corporate women, fashion, and the millennial generation.

Matt Stewart, Global Marketing Manager, IQVIA

Matt is responsible for content development and global content strategy at IQVIA MedTech, and is your host for this live webinar, leading the conversation and asking our panel your questions.

Hear From Us

Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.